yourstate.us
42 U.S.C. § 263–1

Education on biological products

United States · Title 42 — THE PUBLIC HEALTH AND WELFARE · Status: effective

Get this as JSONEmbed this
Cite this
Citation
42 U.S.C. § 263–1, Education on biological products, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/475327
Permanent ID
ys:prov:475327@1
SHA-256
10c7f29d9c2db6d5c444e31d53eec230976ceef28ce81ef4176222bf04b85d65

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

The Secretary may maintain and operate an internet website to provide educational materials for health care providers, patients, and caregivers, regarding the meaning of the terms, and the standards for review and licensing of, biological products, including biosimilar biological products and interchangeable biosimilar biological products. Educational materials provided under paragraph (1) may include— The educational materials provided under paragraph (1) may be— In addition to the information described in paragraph (2), the Secretary shall continue to publish— This subsection does not authorize the disclosure of any trade secret, confidential commercial or financial information, or other matter described in section 552(b) of title 5. The Secretary shall advance education and awareness among health care providers regarding biological products, including biosimilar biological products and interchangeable biosimilar biological products, as appropriate, including by developing or improving continuing education programs that advance the education of such providers on the prescribing of, and relevant clinical considerations with respect to, biological products, including biosimilar biological products and interchangeable biosimilar biological products.

Legislative history

The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone.

  • Enacted byPub. L. 117-8(S. 164)2021-04-23
    Advancing Education on Biosimilars Act of 2021
    House: 412–8Senate: no recorded tally